实控人两月内两度被立案,倍轻松“难轻松”
BreoBreo(SH:688793) Xin Jing Bao·2026-02-07 07:19

Core Viewpoint - The company, Beilong, is facing significant regulatory scrutiny and financial challenges, with its actual controller, Ma Xuejun, receiving multiple notices of investigation for alleged market manipulation and information disclosure violations [2][3][12]. Financial Performance - Beilong's stock price closed at 22.71 yuan per share on February 6, 2026, reflecting a decline of 1.13%, with a total market capitalization of approximately 1.95 billion yuan, down over 80% from its peak [2][9]. - The company has issued a profit warning for 2025, projecting a net loss attributable to shareholders of between 84 million and 105 million yuan, marking a reversal from profit to loss [6][16]. - The company's net profit has fluctuated significantly, with profits in 2021 and 2024, but losses in 2022 and 2023, and a projected loss for 2025 [6][16]. Regulatory Issues - Ma Xuejun has received two notices of investigation within two months, one for alleged market manipulation and another for information disclosure violations [3][12]. - Despite these issues, Ma Xuejun continues to perform his duties within the company, and business operations are reported to be normal [4][13]. Corporate Governance and Financial Conduct - There have been instances of Ma Xuejun occupying company funds, totaling 408,230 yuan through employee loans, which have since been repaid [5][15]. - The company has also made advance payments to suppliers, which were subsequently redirected to Ma Xuejun's affiliates, amounting to 800,000 yuan [5][15]. Market Position and Strategy - Beilong, known as the "first stock of smart massage devices," is involved in the design, research, production, sales, and service of portable health hardware [6][16]. - Analysts suggest that to reverse its declining performance, Beilong should focus on product innovation, channel optimization, cost control, and brand repositioning [17].

Breo-实控人两月内两度被立案,倍轻松“难轻松” - Reportify